Palvella Therapeutics (PVLA) PT Raised to $270 at H.C. Wainwright

March 24, 2026 10:53 AM

H.C. Wainwright analyst Andrew Fein raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $270.00 (from $255.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found